Vaccination of diffuse large B- cell lymphoma patients with antigen-primed dendritic cells

Acta Medica Iranica

Volumn 51, Issue 5, 2013, Pages 284-288

  Abediankenari, Saeid ^a   Mollae, Ghasem Janbabaei ^b   Ghasemi, Maryam ^b   Yousefzadeh, Yousef ^a   Bahrami, Masoud ^c   Alimoghaddam, Kamran ^d  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dendritic cell; Lymphoma; Vaccine

Indexed keywords

BETA 2 MICROGLOBULIN; CD14 ANTIGEN; CD83 ANTIGEN; DENDRITIC CELL VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LACTATE DEHYDROGENASE; CANCER VACCINE;

ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL MATURATION; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INGUINAL LYMPH NODE; LARGE CELL LYMPHOMA; MALE; MONOCYTE; MTT ASSAY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; TUMOR VOLUME; VACCINATION; CELLULAR IMMUNITY; COMPARATIVE STUDY; DENDRITIC CELL; FOLLOW UP; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR CELL CULTURE;

ADOLESCENT; ADULT; CANCER VACCINES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; INJECTIONS, SUBCUTANEOUS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; T-LYMPHOCYTES; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; VACCINATION; YOUNG ADULT;

EID: 84886621569     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Turnis ME, Rooney CM. Enhancement of dendritic cells as vaccines for cancer. Immunotherapy 2010; 2(6):847-62.
2. Tawab A, Fan Y, Read EJ, Kurlander RJ. Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes. Transfusion 2009;49(3):536-47
3. Hussin HN, Zulkifli FN, Phang KS, Cheong SK. Dendritic cell distribution in lymphomas. Malays J Pathol 2009;31(2):105-12
4. Sriram MI, Kanth SB, Kalishwaralal K, Gurunathan S. Antitumor activity of silver nanoparticles in Dalton, s lymphoma ascites tumor model. Int J Nanomedicine 2010;5:753-62
5. Saeid Abediankenari, Yousef Yousefzadeh, Hossein Azadeh, Mohammad Vahedi. Comparison of several maturation inducing factors in dendritic cell differentiation. Iran J Immuno 2010;l 7(2): 83-8
6. Mlief CJ. Cancer Immunotherapy by dendritic cells. Immunity 2008;29(3):372-83
7. Brossart P, Stuhler G, Flad T, Stevanovic S, Rammensee HG, Kanz L, Brugger W. Her-2/neu derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Cancer Res 1998;58(4):732-6
8. Flowers CR, Sinha R, Vose JM. Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J Clin 2010; 60(6):393-408.
9. Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development.J. Clin. Invest 2007; 117(5):1155-66.
10. Kim HS, Choo YS, Koo T Bang S, Oh TY, Wen J, et al. Enhancement antitumor in immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer. Immunol Lett 2006;103(2):142-8.
11. Timmerman J. M, Levy R. Dendritic cell vaccines for cancer immunotherapy. Annu Rev Med 1999; 50:507-29.
12. Nabavi H, Jasanbi B, Reece A, Clayton A, Tabi Z, Donninger C, Mason M, Adams M. A clinical grade polyI:C-analogue(Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Vaccine 2009; 27(1):107-15.
13. Schnurr M, Galambos P, Scholz C, Then F, Dauer M, Endres S, et al. Tumor cell lysate-pulsed human dendritic cells induce a Tcell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccine. Cancer Res 2001;61(17):6445-50
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65(1-2): 55-63
15. Finn OJ. Cancer immunology. N Engl J Med 2008:358(25);2704-15
16. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunology 2003:21;685-711.
17. Steinman RM, Bancheau J. Taking dendritic cells into medicine. Nature 2007:449(7161);419-26.
18. Brossart P, Wirths S, Stuhler G, Reichardt V. L, Kanz L, Brugger W. Induction of cytotoxic T-lymphocyte responses in vivo after vaccination with peptide-pulsed dendritic cells. Blood 2000;96(9): 3102-8.